US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

704.51

+15.042.18%

Number of Gainers:45

Number of Losers:99

Number of Flat:9

PE:- -

High:706.55

Open:689.67

Low:689.64

Close:689.58

Volume:146.89M

Turnover:6.93B

Market Cap:486.62B

Float Cap:370.67B

Loading ...

SimilarWeb CEO or Offer or Sells USD 1.2 Million in Common Shares

Digital Brands Group Says U.S. Program Contract Guarantees USD 3.3 Million Cash Flow Through Dec. 31

Agilon Health expands relationship with Family Practice Center

Agilon Health Expands Partnership with Family Practice Center Via Senior Health Connect ACO

Kaltura CFO Azaria Eynav Disposes of USD 33,272 in Common Shares

Candel Therapeutics Adds Independent Director to Board

Eco Wave Power to Present at H.C. Wainwright Global Investment Conference

Erasca to Present Updated Phase 1 Auroras-1 Monotherapy Data for ERAS-0015 at ENA Symposium

Candel Therapeutics Appoints Martine Zimmermann, Pharmd, to Its Board of Directors

THOMSON REUTERS

Press Release: Candel Therapeutics Appoints Martine Zimmermann, PharmD, to Its Board of Directors

Similarweb Ecommerce Report Says AI Shopping Recommendations Sway Purchases Despite Limited Click-Through Traffic

Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference

Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium

Upexi price target raised to $2 from $1.30 at Cantor Fitzgerald

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

HCW Biologics Updates Special Meeting Proxy Materials

Indaptus Therapeutics Announces Private Equity Financing Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4539/news?page=24"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":704.617,"timestamp":1789749618063,"preClose":689.5794,"halted":0,"volume":146877843,"delay":0,"changeRate":0.021807,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":15.037598,"latestTime":"09-18 12:40:18 EDT","open":689.67395,"high":706.54535,"low":689.6394,"amount":6929290810.955191,"amplitude":0.024516,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.238276,"peRate":114.534565,"turnoverRate":0.011493,"increases":45,"decrements":99,"flats":6,"marketCap":486615313610.25,"floatMarketCap":370674751316.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":706.54535,"amplitude":0.024516,"preClose":689.5794,"low":689.6394,"pbRate":"5.238276","latestPrice":704.5051,"volume":146885869,"delay":0,"open":689.67395,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":693.0266,"twentyDayClose":673.0297,"sixtyDayClose":707.541,"secType":"PLATE","market":"US","turnoverRate":0.011493,"peRate":114.534565,"marketCap":486615313610.25,"floatMarketCap":370674751316.25,"timestamp":1789749620094,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":45,"down":99,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:24,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666859605","title":"SimilarWeb CEO or Offer or Sells USD 1.2 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666859605","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666859605?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:29","pubTimestamp":1789046953,"startTime":"0","endTime":"0","summary":"SimilarWeb CEO Or Offer Or sells USD 1.2 million in common sharesSimilarWeb CEO Or Offer sold 147,000 ordinary shares on Sept. 8-9, 2026.Sales averaged USD 8.33 on Sept. 8, USD 8.06 on Sept. 9.Direct ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9ND90q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SimilarWeb CEO or Offer or Sells USD 1.2 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SMWB","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666359694","title":"Digital Brands Group Says U.S. Program Contract Guarantees USD 3.3 Million Cash Flow Through Dec. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2666359694","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666359694?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:12","pubTimestamp":1789045945,"startTime":"0","endTime":"0","summary":"Digital Brands Group says U.S. program contract guarantees USD 3.3 million cash flow through Dec. 31Digital Brands Group issued an investor update to rebut online rumors, citing a binding $165 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2y9gGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","DBGI","BK4094","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666962435","title":"Agilon Health expands relationship with Family Practice Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2666962435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666962435?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:05","pubTimestamp":1789045518,"startTime":"0","endTime":"0","summary":"agilon health (AGL) announced the expansion of its relationship with Family Practice Center, PC in Pennsylvania, which will join one of agilon’s Se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agilon-health-expands-relationship-with-family-practice-center-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agilon-health-expands-relationship-with-family-practice-center-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4539","PC","BK4196","AGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596350","title":"Agilon Health Expands Partnership with Family Practice Center Via Senior Health Connect ACO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596350","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596350?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:02","pubTimestamp":1789045342,"startTime":"0","endTime":"0","summary":"agilon health expands partnership with Family Practice Center via Senior Health Connect ACOagilon health expanded its relationship with Family Practice Center in Pennsylvania through a Senior Health Connect ACO.Family Practice Center entered a long-term agreement to move certain Traditional Medicare patients to full-risk value-based care starting 2024.The ACO participates in the Medicare Shared Savings Program, targeting higher care coordination while reducing unnecessary healthcare spending.Since 2021, agilon’s ACOs generated more than $510 million in gross savings, including $125 million in savings to the Medicare Trust Fund.In 2024, agilon’s ACOs posted an average quality score of 96%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL7r9fcC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4539","AGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595975","title":"Kaltura CFO Azaria Eynav Disposes of USD 33,272 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595975","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595975?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:49","pubTimestamp":1789044563,"startTime":"0","endTime":"0","summary":"Kaltura CFO Azaria Eynav disposes of USD 33,272 in common sharesAzaria Eynav, officer, sold 22,419 Kaltura common shares on Sept. 8-9, 2026 at about USD 1.48 a share.Beneficial ownership fell to 2,019","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2n8Swz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kaltura CFO Azaria Eynav Disposes of USD 33,272 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","KLTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666963515","title":"Candel Therapeutics Adds Independent Director to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666963515","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666963515?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:48","pubTimestamp":1789044520,"startTime":"0","endTime":"0","summary":"Candel Therapeutics ( ($CADL) ) has shared an announcement. On September 6, 2026, Candel Therapeutics’ board expanded from ten to eleven members an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-adds-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-adds-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593743","title":"Eco Wave Power to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593743","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593743?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:31","pubTimestamp":1789043511,"startTime":"0","endTime":"0","summary":"Eco Wave Power to Present at H.C. Wainwright Global Investment ConferenceEco Wave Power will attend H.C. Wainwright’s 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York.CEO Inn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6Lt4hq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4133","WAVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938495","title":"Erasca to Present Updated Phase 1 Auroras-1 Monotherapy Data for ERAS-0015 at ENA Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938495?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:05","pubTimestamp":1789041947,"startTime":"0","endTime":"0","summary":"Erasca to present updated Phase 1 AURORAS-1 monotherapy data for ERAS-0015 at ENA SymposiumErasca flagged updated Phase 1 AURORAS-1 monotherapy results for ERAS-0015 for future presentation at the ENA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1xh5rb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4588","SG9999014005.SGD","SG9999014013.SGD","SG9999014039.USD","BK4539","ERAS","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","NDAQ","BK4139","SG9999014021.USD","BCDF","BK4112","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593868","title":"Candel Therapeutics Appoints Martine Zimmermann, Pharmd, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593868","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593868?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:05","pubTimestamp":1789041900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA6TWHFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666381593","title":"Press Release: Candel Therapeutics Appoints Martine Zimmermann, PharmD, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666381593","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666381593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:05","pubTimestamp":1789041900,"startTime":"0","endTime":"0","summary":"-- Regulatory and quality expertise strengthens Board as Candel advances","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4604","DNA","BK4099","TM","03160","BK4109","IDNA","BK4585","BK4555","BK4139","BK4539","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598080","title":"Similarweb Ecommerce Report Says AI Shopping Recommendations Sway Purchases Despite Limited Click-Through Traffic","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598080?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:01","pubTimestamp":1789041717,"startTime":"0","endTime":"0","summary":"Similarweb ecommerce report says AI shopping recommendations sway purchases despite limited click-through trafficSimilarweb’s State of Ecommerce 2026 report flags AI chat tools as a high-impact influe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9S1pGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","SMWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593597","title":"Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593597","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593597?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041600,"startTime":"0","endTime":"0","summary":"Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debtORANGE, Calif., Sept.  10, 2026 (GLOBE NEWSWIRE) -- Ninety percent of seniors report at least one fa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359411/0/en/alignment-health-s-fifth-annual-survey-finds-seniors-falling-further-behind-aging-in-place-challenges-continue-to-rise-as-support-gaps-widen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4550","ALHC","BK4588","BK4585","BK4154","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593537","title":"Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041600,"startTime":"0","endTime":"0","summary":"DOYLESTOWN, Pa., Sept.  10, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359416/0/en/aprea-therapeutics-to-present-at-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666593519","title":"IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666593519","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666593519?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041600,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for ca","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359436/0/en/in8bio-to-present-at-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536593","title":"Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536593","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041600,"startTime":"0","endTime":"0","summary":"Oral presentation to share updated monotherapy clinical data for ERAS-0015 including additional patients and longer follow-up, expanding on the previously reported preliminary results from the ongoing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359447/0/en/erasca-announces-multiple-presentations-at-the-upcoming-38th-eortc-nci-aacr-symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","LU0572939691.SGD","BK4181","ERAS","BK4218","LU0572940350.SGD","LU0264606111.USD","01336","BK1550","PK","ADME","BK1184","BK4139","BK1584","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598237","title":"Upexi price target raised to $2 from $1.30 at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598237?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:55","pubTimestamp":1789041326,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Brett Knoblauch raised the firm’s price target on Upexi (UPXI) to $2 from $1.30 and keeps an Overweight rating on the sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upexi-price-target-raised-to-2-from-1-30-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upexi-price-target-raised-to-2-from-1-30-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPXI","BK4539","PXIU","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598627","title":"CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598627","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598627?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:33","pubTimestamp":1789039980,"startTime":"0","endTime":"0","summary":"Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina Com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359400/0/en/camp4-therapeutics-receives-authorization-in-the-united-kingdom-for-phase-1-2-human-clinical-trial-of-cmp-002-in-patients-with-syngap1-related-disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","BK4168","BK4139","CMP","LENZ","NVIB","GDOC","HYLG","BK4200","UBCP","MEDX","BK4211","BK4561","IDNA","ASO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598673","title":"Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598673","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598673?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039800,"startTime":"0","endTime":"0","summary":"- Expands on previously reported findings in which 84% of evaluable first-line PDAC patients treated with atebimetinib + mGnP maintained or gained weight at three months - - New analyses evaluate the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359390/0/en/immuneering-to-present-at-the-aacr-conference-on-pancreatic-cancer-highlighting-atebimetinib-s-dual-mechanism-for-extended-survival.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567569","title":"HCW Biologics Updates Special Meeting Proxy Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567569?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036582,"startTime":"0","endTime":"0","summary":"The latest announcement is out from HCW Biologics ( ($HCWB) ). On September 9, 2026, HCW Biologics Inc. filed Amendment No. 1 to its Preliminary Pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-updates-special-meeting-proxy-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-updates-special-meeting-proxy-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UYM","BK4539","BK4139","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567597","title":"Indaptus Therapeutics Announces Private Equity Financing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567597?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:33","pubTimestamp":1789036403,"startTime":"0","endTime":"0","summary":"An update from Indaptus Therapeutics ( ($INDP) ) is now available. On September 8, 2026, Indaptus Therapeutics entered into a Stock Purchase Agreem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indaptus-therapeutics-announces-private-equity-financing-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indaptus-therapeutics-announces-private-equity-financing-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4007","BK4588","LENZ","BK4585","REZ","BK4139","EQR","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":24,"totalSize":797,"code":"91000000","status":"200"}]}}